Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer
- 20 February 2014
- journal article
- research article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 15 (5) , 570-577
Abstract
Use of the inhibitor of ALK fusion onco-protein, crizotinib (PF02341066), has achieved impressive clinical efficacy in patients with ALK-positive non-small cell lung cancer. Nevertheless, acquired resistance to this drug occurs inevitably in approximately a year, limiting the therapeutic benefits of this novel targeted therapy. In this study, we found that autophagy was induced in crizonitib-resistant lung cancer cells and contributed to drug resistance. We observed that ALK was downregulated in the crizotinib-resistant lung cancer cell line, H3122CR-1, and this was causally associated with autophagy induction. The degree of crizotinib resistance correlated with autophagic activity. Activation of autophagy in crizotinib-resistant H3122CR-1 cells involved alteration of the Akt/mTOR signaling pathway. Furthermore, we demonstrated that chloroquine, an inhibitor of autophagy, could restore sensitivity of H3122CR-1 to crizotinib and enhance its efficacy against drug-resistant lung cancer. Thus, modulating autophagy may be worth exploring as a new strategy to overcome acquired crizonitib resistance in ALK-positive lung cancer.Keywords
This publication has 23 references indexed in Scilit:
- Mechanistic insight into ALK receptor tyrosine kinase in human cancer biologyNature Reviews Cancer, 2013
- Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung CancerJournal of Thoracic Oncology, 2010
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK InhibitorsNew England Journal of Medicine, 2010
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- ERK and cell death: Mechanisms of ERK‐induced cell death – apoptosis, autophagy and senescenceThe FEBS Journal, 2009
- ERK and JNK mediate TNFα-induced p53 activation in apoptotic and autophagic L929 cell deathBiochemical and Biophysical Research Communications, 2008
- Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agentsJournal of Cell Biology, 2008
- Inhibition of autophagy at a late stage enhances imatinib‐induced cytotoxicity in human malignant glioma cellsInternational Journal of Cancer, 2008
- EML4-ALKFusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung CancerClinical Cancer Research, 2008
- Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathwayOncogene, 2007